Qiu Li
Merck & Co.
3 Papers
26 Citations
Qiu Li is an academic researcher from Merck & Co.. The author has contributed to research in topics: Nicotinic agonist & Antithrombotic. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia.
Anandan Palani,Ashwin U. Rao,Xia Chen,Xianhai Huang,Jing Su,Huadong Tang,Yuhua Huang,Jun Qin,Dong Xiao,Sylvia J. Degrado,Michael Sofolarides,Xiaohong Zhu,Zhidan Liu,Mckittrick Brian A,Wei Zhou,Robert G. Aslanian,William J. Greenlee,Boonlert Cheewatrakoolpong,Hongtao Zhang,Farley C,Jacquelynn J. Cook,Stan Kurowski,Qiu Li,van Heek M,Wang G,Yunsheng Hsieh,Fangbiao Li,Scott Greenfeder,Madhu Chintala +28 more
TL;DR: Structure-guided optimization of a series of C-5 alkyl substituents led to the discovery of a potent nicotinic acid receptor agonist SCH 900271 (33) with an EC50 of 2 nM in the hu-GPR109a assay.
Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the Arterio-Venous shunt model of thrombosis.
Jin Shang,Zhu Chen,Min Wang,Qiu Li,Wen Feng,Yangsong Wu,Weizhen Wu,Michael P. Graziano,Madhu Chintala +8 more
TL;DR: Assessing coagulability, platelet reactivity, and thrombogenicity of the diabetic female Zucker Diabetic Fatty (ZDF) rat model and its relevance in studying antithrombotic mechanisms shed new light on the pathophysiology of the ZDF model and illustrate its potential value in translational research on anticoagulant agents in diabetics.
22
A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apcmin/+ mice
TL;DR: The results indicate that the Apc(min/+) mouse may be a sensitive preclinical model for assessing the spontaneous GI bleeding risk of novel antithrombotic agents.
7